ARAY
Accuray IncorporatedNASDAQHealthcare$0.42+6.82%ClosedMarket Cap: $49.3M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.94
P/S
0.11
EV/EBITDA
-102.29
DCF Value
$1.72
FCF Yield
-12.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
27.7%
Operating Margin
-2.6%
Net Margin
-8.2%
ROE
-57.9%
ROA
-8.0%
ROIC
-4.3%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q2 2026 | $102.2M | 23.5% | $-5.5M | $-13.8M | $-0.11 | — |
| Q1 2026 | $93.9M | 28.3% | $-11.3M | $-21.7M | $-0.18 | — |
| Q4 2025 | $127.5M | 30.6% | $4.2M | $1.1M | $0.01 | — |
| FY 2025 | $458.5M | 32.1% | $7.8M | $-1.6M | $-0.02 | — |
| Q3 2025 | $113.2M | 27.9% | $1.0M | $-1.3M | $-0.01 | — |
| Q2 2025 | $116.2M | 36.1% | $4.7M | $2.5M | $0.02 | — |
| Q1 2025 | $101.5M | 33.9% | $-2.1M | $-4.0M | $-0.04 | — |
| Q4 2024 | $134.3M | 28.6% | $6.8M | $3.4M | $0.03 | — |
| FY 2024 | $446.6M | 32.0% | $504.0K | $-15.5M | $-0.16 | — |
| Q3 2024 | $101.1M | 28.7% | $-4.6M | $-6.3M | $-0.06 | — |
| Q2 2024 | $107.2M | 33.5% | $-4.0M | $-9.6M | $-0.10 | — |
| Q1 2024 | $103.9M | 38.0% | $2.2M | $-3.0M | $-0.03 | — |